Biology:UDP-3-O-acyl-N-acetylglucosamine deacetylase

From HandWiki
Short description: Type of enzyme

UDP-3-O-acyl-N-acetylglucosamine deacetylase
Identifiers
EC number3.5.1.108
Databases
IntEnzIntEnz view
BRENDABRENDA entry
ExPASyNiceZyme view
KEGGKEGG entry
MetaCycmetabolic pathway
PRIAMprofile
PDB structuresRCSB PDB PDBe PDBsum

UDP-3-O-acyl-N-acetylglucosamine deacetylase (EC 3.5.1.108), also known as LpxC, is a zinc-dependent enzyme involved in bacterial lipid A biosynthesis, catalyzing the removal of the acetyl group from UDP-3-O-acyl-N-acetylglucosamine, a key step in the production of lipopolysaccharides in the outer membrane of gram-negative bacteria.[1][2][3][4][5][6]

This enzyme catalyses the chemical reaction:

UDP-3-O-[(3R)-3-hydroxymyristoyl]-N-acetylglucosamine + H2O UDP-3-O-[(3R)-3-hydroxymyristoyl]-D-glucosamine + acetate

Nomenclature

UDP-3-O-acyl-N-acetylglucosamine deacetylase is also known as:

  • UDP-3-O-((3R)-3-hydroxymyristoyl)-N-acetylglucosamine amidohydrolase
  • LpxC enzyme
  • LpxC deacetylase
  • deacetylase LpxC
  • UDP-3-O-acyl-GlcNAc deacetylase
  • UDP-3-O-((R)-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase
  • UDP-(3-O-acyl)-N-acetylglucosamine deacetylase
  • UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase
  • UDP-(3-O-(R-3-hydroxymyristoyl))-N-acetylglucosamine deacetylase)

Inhibitors

Various inhibitors of LpxC have been developed as potential antibiotics, though none have yet reached clinical trials.[7][8][9]

References

  1. "UDP-3-O-((R)-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase functions through a general acid–base catalyst pair mechanism". The Journal of Biological Chemistry 280 (17): 16969–78. April 2005. doi:10.1074/jbc.M413560200. PMID 15705580. 
  2. "UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase of Escherichia coli is a zinc metalloenzyme". Biochemistry 38 (6): 1902–11. February 1999. doi:10.1021/bi982339s. PMID 10026271. 
  3. "Cloning, expression, and purification of UDP-3-O-acyl-GlcNAc deacetylase from Pseudomonas aeruginosa: a metalloamidase of the lipid A biosynthesis pathway". Journal of Bacteriology 179 (6): 2029–37. March 1997. doi:10.1128/jb.179.6.2029-2037.1997. PMID 9068651. 
  4. "A fluorescence-based homogeneous assay for measuring activity of UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase". Analytical Biochemistry 290 (2): 338–46. March 2001. doi:10.1006/abio.2000.4973. PMID 11237337. 
  5. "Crystal structure of LpxC, a zinc-dependent deacetylase essential for endotoxin biosynthesis". Proceedings of the National Academy of Sciences of the United States of America 100 (14): 8146–50. July 2003. doi:10.1073/pnas.1432990100. PMID 12819349. Bibcode2003PNAS..100.8146W. 
  6. "Crystal structure of LpxC from Pseudomonas aeruginosa complexed with the potent BB-78485 inhibitor". Protein Science 17 (3): 450–7. March 2008. doi:10.1110/ps.073324108. PMID 18287278. 
  7. "Insights into the Zinc-Dependent Deacetylase LpxC: Biochemical Properties and Inhibitor Design". Current Topics in Medicinal Chemistry 16 (21): 2379–2430. 2016. doi:10.2174/1568026616666160413135835. PMID 27072691. 
  8. "LpxC inhibitors: a patent review (2010-2016)". Expert Opinion on Therapeutic Patents 27 (11): 1227–1250. November 2017. doi:10.1080/13543776.2017.1360282. PMID 28742403. 
  9. "Small molecule LpxC inhibitors against gram-negative bacteria: Advances and future perspectives". European Journal of Medicinal Chemistry 253. May 2023. doi:10.1016/j.ejmech.2023.115326. PMID 37023679. 
  10. "Inhibitor Assessment against the LpxC Enzyme of Antibiotic-resistant Acinetobacter baumannii Using Virtual Screening, Dynamics Simulation, and in vitro Assays". Molecular Informatics 42 (2). February 2023. doi:10.1002/minf.202200061. PMID 36289054. 
  11. "TP0586532, a non-hydroxamate LpxC inhibitor, has in vitro and in vivo antibacterial activities against Enterobacteriaceae". The Journal of Antibiotics 75 (2): 98–107. February 2022. doi:10.1038/s41429-021-00486-3. PMID 34837061.